| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Antazoline | Antazoline EP Impurity A | VL6670002 | View CAS 26953-37-7 |
Antazoline Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Antazoline | Antazoline EP Impurity A | VL6670002 | View CAS 26953-37-7 |
| Catalogue No. | VL6670002 |
| CAS No. | 26953-37-7 |
| Molecular Formula | C17H21N3O |
| Molecular Weight | 283.37 g/mol |
| Parent drug | Antazoline |
| IUPAC Name | N-(2-Aminoethyl)-2-(benzyl(phenyl)amino)acetamide |
| Synonyms | Antazoline Related Compound A |
| References | Shah, S. S., et al. “Antazoline in the Treatment of Cardiac Arrhythmias.” Postgraduate Medical Journal, vol. 48, no. 559, 1 May 1972, pp. 304–307, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2495299/. Accessed 26 Jan. 2022. |
| Status | In-stock |
| ListName | Antazoline EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
